Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Amortizatization of Intangibles (2016 - 2021)

Conmed (CNMD) has disclosed Amortizatization of Intangibles for 12 consecutive years, with $2.6 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Amortizatization of Intangibles rose 6.24% year-over-year to $2.6 million, compared with a TTM value of $2.6 million through Sep 2022, down 74.11%, and an annual FY2021 reading of $10.2 million, up 5.42% over the prior year.
  • Amortizatization of Intangibles was $2.6 million for Q4 2021 at Conmed, up from $2.6 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $10.8 million in Q3 2018 and bottomed at -$32.3 million in Q4 2018.
  • Average Amortizatization of Intangibles over 5 years is $3.3 million, with a median of $2.5 million recorded in 2021.
  • The sharpest move saw Amortizatization of Intangibles plummeted 445.47% in 2018, then surged 107.0% in 2019.
  • Year by year, Amortizatization of Intangibles stood at $9.4 million in 2017, then tumbled by 445.47% to -$32.3 million in 2018, then skyrocketed by 107.0% to $2.3 million in 2019, then grew by 8.35% to $2.5 million in 2020, then rose by 6.24% to $2.6 million in 2021.
  • Business Quant data shows Amortizatization of Intangibles for CNMD at $2.6 million in Q4 2021, $2.6 million in Q3 2021, and $2.5 million in Q2 2021.